ACP-101

Acadia gives once-rejected Prader-Willi drug a second chance
BioPharma Dive
Wed, 06/14/23 - 06:40 pm
Acadia Pharmaceuticals
Prader-Willi Syndrome
clinical trials
ACP-101
Carbetocin